Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ME

23andMe (ME) Stock Price, News & Analysis

23andMe logo

About 23andMe Stock (NASDAQ:ME)

Advanced Chart

Key Stats

Today's Range
$0.60
$1.10
50-Day Range
$0.50
$0.50
52-Week Range
$0.53
$9.57
Volume
29.28 million shs
Average Volume
1.55 million shs
Market Capitalization
$13.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Receive ME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 23andMe and its competitors with MarketBeat's FREE daily newsletter.

ME Stock News Headlines

A 23andMe saliva collection kit is shown on March 25, 2025, in Oakland, Calif
Anne Wojcicki's nonprofit gets court approval to buy 23andMe for $305 million
Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to buy 23andMe — the genetic testing company she cofounded...
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

ME Stock Analysis - Frequently Asked Questions

23andMe Holding Co. (NASDAQ:ME) announced its earnings results on Tuesday, January, 28th. The company reported ($1.02) EPS for the quarter. 23andMe had a negative net margin of 183.39% and a negative trailing twelve-month return on equity of 170.07%.

23andMe's stock reverse split on the morning of Wednesday, October 16th 2024.The 1-20 reverse split was announced on Friday, October 11th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, October 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that 23andMe investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
1/28/2025
Today
7/20/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ME
CIK
1804591
Fax
N/A
Employees
770
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.45)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$666.70 million
Net Margins
-183.39%
Pretax Margin
-186.76%
Return on Equity
-170.07%
Return on Assets
-62.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.05
Quick Ratio
0.91

Sales & Book Value

Annual Sales
$208.78 million
Price / Sales
0.06
Cash Flow
$0.54 per share
Price / Cash Flow
0.93
Book Value
$2.34 per share
Price / Book
0.21

Miscellaneous

Outstanding Shares
26,827,000
Free Float
19,766,000
Market Cap
$13.36 million
Optionable
Not Optionable
Beta
1.19
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ME) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners